HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N-Acetylcysteine for thrombotic thrombocytopenic purpura: is a von Willebrand factor-inhibitory dose feasible in vivo?

AuthorsJake Shortt, Stephen S Opat, Erica M Wood
JournalTransfusion (Transfusion) Vol. 54 Issue 9 Pg. 2362-3 (Sep 2014) ISSN: 1537-2995 [Electronic] United States
PMID25212426 (Publication Type: Letter, Comment)
Chemical References
  • Acetylcysteine
Topics
  • Acetylcysteine (therapeutic use)
  • Female
  • Humans
  • Purpura, Thrombotic Thrombocytopenic (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: